“PD-1 and PDL-1 Immune Checkpoint Inhibitors: Emerging Hope for the Future of Lung Cancer Immunotherapy” (2025) Healthy Tadulako Journal (Jurnal Kesehatan Tadulako), 11(3), pp. 445–454. doi:10.22487/htj.v11i3.1723.